BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9506560)

  • 1. Complex I defect in muscle from patients with Huntington's disease.
    Arenas J; Campos Y; Ribacoba R; Martín MA; Rubio JC; Ablanedo P; Cabello A
    Ann Neurol; 1998 Mar; 43(3):397-400. PubMed ID: 9506560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial defect in Huntington's disease caudate nucleus.
    Gu M; Gash MT; Mann VM; Javoy-Agid F; Cooper JM; Schapira AH
    Ann Neurol; 1996 Mar; 39(3):385-9. PubMed ID: 8602759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.
    Browne SE; Bowling AC; MacGarvey U; Baik MJ; Berger SC; Muqit MM; Bird ED; Beal MF
    Ann Neurol; 1997 May; 41(5):646-53. PubMed ID: 9153527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCR analysis of platelet mtDNA: lack of specific changes in Parkinson's disease.
    Sandy MS; Langston JW; Smith MT; Di Monte DA
    Mov Disord; 1993; 8(1):74-82. PubMed ID: 8419811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.
    Browne SE
    Ann N Y Acad Sci; 2008 Dec; 1147():358-82. PubMed ID: 19076457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia.
    Schapira AH
    Biochim Biophys Acta; 1999 Feb; 1410(2):159-70. PubMed ID: 10076024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive exercise intolerance associated with a new muscle-restricted nonsense mutation (G142X) in the mitochondrial cytochrome b gene.
    Bruno C; Santorelli FM; Assereto S; Tonoli E; Tessa A; Traverso M; Scapolan S; Bado M; Tedeschi S; Minetti C
    Muscle Nerve; 2003 Oct; 28(4):508-11. PubMed ID: 14506725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients.
    Swerdlow RH; Parks JK; Cassarino DS; Shilling AT; Bennett JP; Harrison MB; Parker WD
    Biochem Biophys Res Commun; 1999 Aug; 261(3):701-4. PubMed ID: 10441489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear DNA origin of mitochondrial complex I deficiency in fatal infantile lactic acidosis evidenced by transnuclear complementation of cultured fibroblasts.
    Procaccio V; Mousson B; Beugnot R; Duborjal H; Feillet F; Putet G; Pignot-Paintrand I; Lombès A; De Coo R; Smeets H; Lunardi J; Issartel JP
    J Clin Invest; 1999 Jul; 104(1):83-92. PubMed ID: 10393702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene.
    Mancuso M; Filosto M; Bonilla E; Hirano M; Shanske S; Vu TH; DiMauro S
    Arch Neurol; 2003 Jul; 60(7):1007-9. PubMed ID: 12873860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease.
    Pandey M; Varghese M; Sindhu KM; Sreetama S; Navneet AK; Mohanakumar KP; Usha R
    J Neurochem; 2008 Jan; 104(2):420-34. PubMed ID: 17953654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex I deficiency in Persian multiple sclerosis patients.
    Kumleh HH; Riazi GH; Houshmand M; Sanati MH; Gharagozli K; Shafa M
    J Neurol Sci; 2006 Apr; 243(1-2):65-9. PubMed ID: 16413582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.
    Chen CM; Wu YR; Cheng ML; Liu JL; Lee YM; Lee PW; Soong BW; Chiu DT
    Biochem Biophys Res Commun; 2007 Jul; 359(2):335-40. PubMed ID: 17543886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory chain and mitochondrial deoxyribonucleic acid in blood cells from patients with focal and generalized dystonia.
    Reichmann H; Naumann M; Hauck S; Janetzky B
    Mov Disord; 1994 Nov; 9(6):597-600. PubMed ID: 7845398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10.
    Koroshetz WJ; Jenkins BG; Rosen BR; Beal MF
    Ann Neurol; 1997 Feb; 41(2):160-5. PubMed ID: 9029064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA haplogroups do not influence the Huntington's disease phenotype.
    Mancuso M; Kiferle L; Petrozzi L; Nesti C; Rocchi A; Ceravolo R; Orsucci D; Maluccio MR; Bonuccelli U; Filosto M; Siciliano G; Murri L
    Neurosci Lett; 2008 Oct; 444(1):83-6. PubMed ID: 18706972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult onset limb-girdle type mitochondrial myopathy with a mitochondrial DNA np8291 A-to-G substitution.
    Hirata K; Nakagawa M; Higuchi I; Hashimoto K; Hanada K; Takahashi K; Niiyama T; Izumi K; Sakoda S; Yamada H; Osame M
    J Hum Genet; 1999; 44(3):210-4. PubMed ID: 10319590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.
    Trimmer PA; Swerdlow RH; Parks JK; Keeney P; Bennett JP; Miller SW; Davis RE; Parker WD
    Exp Neurol; 2000 Mar; 162(1):37-50. PubMed ID: 10716887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation.
    Auré K; Fayet G; Leroy JP; Lacène E; Romero NB; Lombès A
    Brain; 2006 May; 129(Pt 5):1249-59. PubMed ID: 16537564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.